LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - uniQure (NASDAQ: QURE)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ QURE uniQure
Kapusta Matthew C / director, officer: CEO, Managing Director
12/10/2024
Buy
$14.71
100,000
$1.471M
697,915
NASDAQ QURE uniQure
Kapusta Matthew C / director, officer: CEO, Managing Director
12/10/2024
Sell
$15.03
100,000
$1.503M
597,915
NASDAQ QURE uniQure
Kapusta Matthew C / director, officer: CEO, Managing Director
12/10/2024
Sell
$14.71
100,000
$1.471M
0
NASDAQ QURE uniQure
Kapusta Matthew C / director, officer: CEO, Managing Director
12/09/2024
Sell
$7.63
3,418
$26K
597,915
NASDAQ QURE uniQure
KLEMT CHRISTIAN / officer: Chief Financial Officer
12/09/2024
Sell
$7.55
1,796
$14K
166,713

COPYRIGHT ©2023 HEALTH STOCKS HUB